Chemoinformaics analysis of 3,4-Dihydroxyacetophenone
Molecular Weight | 152.149 | nRot | 1 |
Heavy Atom Molecular Weight | 144.085 | nRig | 7 |
Exact Molecular Weight | 152.047 | nRing | 1 |
Solubility: LogS | -1.013 | nHRing | 0 |
Solubility: LogP | 0.87 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 21.1003 |
nHD | 2 | BPOL | 8.89366 |
QED | 0.471 |
Synth | 1.754 |
Natural Product Likeliness | 0.578 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.007 |
HIA | 0.006 |
CACO-2 | -4.602 |
MDCK | 0.0000146 |
BBB | 0.089 |
PPB | 0.612869 |
VDSS | 0.688 |
FU | 0.300789 |
CYP1A2-inh | 0.845 |
CYP1A2-sub | 0.518 |
CYP2c19-inh | 0.125 |
CYP2c19-sub | 0.06 |
CYP2c9-inh | 0.184 |
CYP2c9-sub | 0.766 |
CYP2d6-inh | 0.208 |
CYP2d6-sub | 0.526 |
CYP3a4-inh | 0.301 |
CYP3a4-sub | 0.211 |
CL | 13.195 |
T12 | 0.905 |
hERG | 0.017 |
Ames | 0.385 |
ROA | 0.146 |
SkinSen | 0.731 |
Carcinogencity | 0.359 |
EI | 0.987 |
Respiratory | 0.765 |
NR-Aromatase | 0.011 |
Antiviral | No |
Prediction | 0.817335 |